CGEN
- Compugen Ltd.
()
Overview
Company Summary
Compugen Ltd. (CGEN) is a biomedical company that specializes in artificial intelligence (AI) and computational biology. The company is primarily focused on utilizing their expertise in AI, machine learning, and data analytics to discover and develop novel drug targets and therapeutics.
Compugen's approach involves mining vast amounts of genomic and proteomic data to identify potential drug targets that have the potential to treat various diseases, such as cancer and autoimmune disorders. By integrating predictive algorithms and computational models, the company aims to accelerate the discovery of new drug candidates.
In addition to drug discovery, Compugen also develops AI-based platforms and tools that aid in the prediction and characterization of new targets, drug resistance mechanisms, and biomarkers. These tools enable researchers and pharmaceutical companies to make data-driven decisions throughout the drug development process.
Collaboration is another important aspect of Compugen's operations. The company actively partners with academic institutions, biopharmaceutical companies, and research organizations to leverage their technologies and foster innovation in the field of drug discovery and development.
Overall, Compugen's unique combination of computational biology, AI, and data analytics enables them to play a crucial role in advancing the field of precision medicine by identifying new therapeutic targets and providing cutting-edge tools for drug development.